Ekso Bionics Reports First Quarter 2025 Financial Results
GlobeNewswire· 2025-05-05 20:05
SAN RAFAEL, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2025. Recent Highlights and Accomplishments Strengthened financial position by improving operating cash burn by 43% combined with $3.8 million in net proceeds from the exercise of warrantsNamed National Seating & Mobility (“NSM”) as i ...
AvePoint to Participate in May Investor Conferences
GlobeNewswire News Room· 2025-05-05 20:05
JERSEY CITY, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the global leader in data security, governance and resilience, today announced that members of the Company’s executive management team will present at the following investor conferences: TD Cowen 53rd Annual Technology, Media & Telecom Conference (New York, NY): Thursday, 5/29 at 2:25 pm ET Jefferies Public Technology Conference (Newport Coast, CA): Thursday, 5/29 at 10:30am PT In addition, AvePoint will attend the following inves ...
Denny's Corporation Reports Results for First Quarter 2025
GlobeNewswire News Room· 2025-05-05 20:05
SPARTANBURG, S.C., May 05, 2025 (GLOBE NEWSWIRE) -- Denny’s Corporation (the "Company") (NASDAQ: DENN), owner and operator of Denny's Inc. ("Denny's") and Keke's Inc. ("Keke's"), today reported results for its first quarter ended March 26, 2025 and provided a business update on the Company’s operations. Kelli Valade, Chief Executive Officer, stated, "The beginning of the year has presented significant challenges for consumers, which is evident in our results. Our teams have remained focused on executing aga ...
uniQure to Announce First Quarter 2025 Financial Results
GlobeNewswire· 2025-05-05 20:05
~ uniQure to host inaugural earnings call on Friday, May 9, 2025 at 8:30 a.m. ET ~LEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 05, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report first quarter 2025 financial results before market open on Friday, May 9, 2025. Management will then host a conference call at 8:30 a.m. ET. As the Company advances its pipeline and AMT-130 toward a BLA ...
Hydrofarm Holdings Group, Inc. to Announce First Quarter 2025 Results on May 13, 2025
GlobeNewswire· 2025-05-05 20:05
SHOEMAKERSVILLE, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (“CEA”), today announced that it will host a conference call to review first quarter 2025 results on Tuesday, May 13, 2025 at 8:30 AM ET. A press release containing first quarter 2025 results will be issued before market open that same day. Th ...
ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates
GlobeNewswire· 2025-05-05 20:05
Announced focused registrational clinical development plans for lead programs, extended cash runway, and accelerated/augmented corporate milestones Presented preclinical data supporting potential best-in-class profile of ORIC-944 in combination with AR inhibitors to treat prostate cancer at the 2025 AACR Annual Meeting Announced clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC-114 in combination with subcutaneous amivantamab for the first-line treatment of NSCLC pati ...
The Vita Coco Company to Participate in the Goldman Sachs Global Staples Forum
GlobeNewswire· 2025-05-05 20:05
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), a leading high-growth platform of better-for-you beverage brands, today announced that the Company will participate in the Goldman Sachs Global Staples Forum on May 13, 2025 in New York, New York. Michael Kirban, Co-Founder and Executive Chairman, will participate in an in-person fireside chat on Tuesday, May 13, 2025 at 10:20 a.m. Eastern Time. The live webcast of the presentation will be a ...
Mineralys Therapeutics to Announce First Quarter 2025 Financial Results and Host Conference Call on Monday, May 12, 2025
GlobeNewswire· 2025-05-05 20:05
RADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the first quarter ended March 31, 2025, after the financial markets close on Monday, May 12, 2025. Monday, May 12th @ 4:30 p.m. ET Domestic:1-800-717 ...
ACV to Participate in Upcoming Investor Conferences
GlobeNewswire· 2025-05-05 20:05
Core Insights - ACV is a leading digital automotive marketplace and data services partner focused on transforming the automotive industry through transparency and comprehensive insights [2] Company Information - ACV offers a range of services including ACV Auctions, ACV Transportation, ACV Capital, ACV MAX, True360, and ClearCar aimed at sourcing, selling, and managing used vehicles [2] - The company is committed to building the most trusted and efficient digital marketplace for the automotive sector [2] Upcoming Events - ACV management will present at the 20th Annual Needham Technology, Media, & Consumer Conference on May 12, 2025, at 2:15 p.m. ET [3] - The company will also participate in the 53rd Annual J.P. Morgan Global Technology, Media and Communications Conference on May 13, 2025, at 3:10 p.m. ET [3]
Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results
GlobeNewswire· 2025-05-05 20:05
MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Summary & Recent Business Highlights: Total revenue increased 0.3% year-over-year to $61.3 millionGross margin of 74% versus 71% in Q1 2024Net loss of $3.0 million versus $2.2 million in Q1 2024Adjusted ...